Press release ¤ Information de presse
07-09 October 2008 , Hannover
Industrial biotechnology, systems biology and molecular medicine are central topics at this year’s European BioPerspectives conference. It takes place in Hannover 07-09 October 2008, in simultaneously to Europe’s most important biotechnology trade show BIOTECHNICA.
An international audience of more than 2,000 is expected at the scientific congress. Six plenary and thirteen keynote lectures provide the basis for more than 120 lectures and an extensive poster session. Topics covered include genomics, the generation and processing of renewable resources as well as biocatalysis and protein engineering, illustrating the broad variety of biotechnology. The platform „White Biotechnology“ shows the current status of activities in Germany. The programme also includes the application-oriented „Science-to-market“-Conference of the European Association of Pharma Biotechnology (EAPB) and the REBIRTH-Conference for regenerative medici-ne of the Hannover Medical School (MHH). This is the fourth BioPerspectives confe-rence; it is one of the most important biotechnology events in Europe.
Global revenue of industrial biotechnology is estimated at 50 billion US$ and expected to grow sixfold over the next ten years. The lecture programme reflects this develop-ment: Michael C. Flickinger (North Carolina State University, Raleigh, USA) opens the conferences with a plenary lecture on functional nanocoatings that contain biologically active microbes. Several lecture sessions are dedicated to biocatalysis, fermentation, downstream processing of biomass and the combination of chemical and biotechnolo-gical methods.
Two plenary lectures illustrate different aspects of systems biology that focuses on organisms as a whole: John Mattick (Univ. of Queensland, Australia) gives an account of recent surprising discoveries in genomics research, especially the various functions of small RNA-molecules. Ruedi Aebersold (ETH Zürich/Institute for Systems Biology, Seattle) describes how proteomics invigorate systems biology. Special sessions cover procaryotic and eucaryotic genomics, proteomics and bioinformatics.
Stem cell research has drawn a lot of attention over the past years. Stephen Minger (King's College, London, UK), whose research on the generation of human stem cells using animal egg cells made the headlines recently, gives an outlook on the future potential of stem cell research. Optimism prevails currently in synthetic biology, too: Wilfried Weber (ETH Zürich) presents artificial ecosystems built of mammal cells and bacteria where signal molecules control coupled synthetic gene networks. Jason Chin (Cambridge University, UK) reports on the re-programming of the proteine synthesis system of bacteria so that they can incorporate synthetic, non-natural amino acids in new proteines.
EAPB’s „Science-to-Market“-Conference that is part of the BioPerspectives program-me on 07 and 08 October aims at promoting the collaboration of science and industry in pharmaceutical biotechnology in order to push the development of marketable tech-nologies and products. The conference focuses on biopharmaceutical drug and di-agnostic developments and novel technologies. The topics will be presented in six workshops and a poster session.
The BioPerspectives programme also includes the renowned REBIRTH conference on regenerative medicine that is organised by the Hannover Medical School (MHH).
By combining BioPerspectives and BIOTECHNIA, the supporting programme could be expanded and made even more attractive. The activities of the VBiO Pupil’s Day have been integrated with the programme „BioTEch4U“ that gives students’ groups the chance to get a close experience of biotechnology and obtain information on study and career opportunities. This programme is offered each day from 07-09 October. The successful offers for networking and identification of potential collaboration partners via an online platform and the jobvector career booth have also found their place within BIOTECHNICA.
The European BioPerspectives is co-organized by 21 partner organisations:
Main organizer is DECHEMA - Gesellschaft für Chemische Technik und Biotechnolo-gie e.V.
DECHEMA e.V. , Theodor-Heuss-Allee 25, 60486 Frankfurt am Main, Germany
Dr. Karsten Schürrle
+49 69 7564 162
+49 69 7564 254
Further information / registration : www.bioperspectives.org
The DECHEMA (Society for Chemical Engineering and Biotechnology) is a non-profit making scientific and technical society based in Frankfurt on Main. It was founded in 1926. Nowadays it has over 5.500 private and institutional members. Our aim is to promote research and technical advances in the areas of chemical engineering, biotechnology and environmental protection. Our work is interdisciplinary, with scientists, engineers, and technologists working together under one roof. Experts from science, business, and government departments cooperate in working parties and subject divisions.